R-ICE versus R-ESHAP for salvage therapy in aggressive B-cell non-Hodgkin lymphoma.

被引：0
|
作者：
Freyer, Craig [1 ]
George, Timothy [1 ]
Price, Samantha [1 ]
Shah, Bijal Dinesh [1 ]
Bello, Celeste M. [1 ]
Sokol, Lubomir [1 ]
Sotomayor, Eduardo M. [1 ]
Cultrera, Jennifer L. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18509
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The efficacy of R-ICE therapy as a salvage treatment for relapse and refractory diffuse large B-Cell lymphoma
    Kodaira, Makoto
    Yokoyama, Masahiro
    Asai, Hiroaki
    Yamada, Shuhei
    Ueda, Kyoko
    Myojo, Tomohiro
    Nishimura, Tomoko
    Mishima, Yuko
    Sakajiri, Sakura
    Takeuchi, Kengo
    Saotome, Takashi
    Terui, Yasuhito
    Takahashi, Shunji
    Hatake, Kiyohiko
    BLOOD, 2007, 110 (11) : 180B - 180B
  • [2] Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma
    Hashmi, Hamza
    Hamadani, Mehdi
    Awan, Farrukh T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (15) : 1631 - 1634
  • [3] R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: A Spanish GEL-TAMO multicenter study
    Martin, Alejandro
    Conde, Eulogio
    Arnan, Montserrat
    Canales, Miguell A.
    Deben, Guillermo
    Andreu, Rafael
    Salar, Antonio
    Garcia-Sanchez, Pedro
    Nistal, Sara
    Requena, Maria J.
    Donato, Eva M.
    Gonzalez, Jose A.
    Leon, Angel
    Ruiz, Concepcion
    Grande, Carlos
    Arranz, Reyes
    Duran, Soledad
    Ortegon, Sergio
    Rodriguez, Juan N.
    Sandoval, Virgilio
    Andreu, Maria A.
    Bernal, Teresa
    Hernandez, Miguel T.
    Gonzalez-Barca, Eva
    Caballero, Maria D.
    BLOOD, 2007, 110 (11) : 1007A - 1008A
  • [4] ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma
    Choi, CW
    Paek, CW
    Seo, JH
    Kim, BS
    Shin, SW
    Kim, YH
    Kim, JS
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (05) : 621 - 624
  • [5] Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell
    Liang, R
    Todd, D
    Ho, FCS
    HEMATOLOGICAL ONCOLOGY, 1996, 14 (01) : 1 - 6
  • [6] The role of salvage therapy post autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma.
    Yano, S
    Sekiguchi, N
    Asai, O
    Dobashi, N
    Sugiyama, K
    Saito, T
    Yahagi, Y
    Osawa, H
    Okawa, Y
    Kasama, K
    Hisatomi, M
    Ueda, K
    Hoshi, Y
    Usui, N
    Kobayashi, M
    BLOOD, 2003, 102 (11) : 483B - 483B
  • [7] Durability of complete response after blinatumomab therapy for refractory/relapsed aggressive B-cell non-Hodgkin lymphoma.
    Viardot, Andreas
    Hess, Georg
    Bargou, Ralf C.
    Morley, Nicholas
    Gritti, Giuseppe
    Iskander, Karim
    Cohan, David
    Zhang, Alicia
    Franklin, Janet
    Coyle, Luke
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome
    Martin, Alejandro
    Caballero, Maria-Dolores
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05): : 744 - 744
  • [9] ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience
    Wang, WS
    Chiou, TJ
    Liu, JH
    Fan, FS
    Yen, CC
    Tung, SL
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (01) : 33 - 37
  • [10] Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation
    Salido Toimil, F.
    Torres Carrete, P.
    Deben Ariznavarreta, G.
    Varela Gomez, M. R.
    Lopez Fernandez, M. F.
    Noriega Concepcion, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S300 - S301
12345